« Back
Home /
Goserelin acetate

Goserelin acetate

Item no.	M1835-50mg
Manufacturer	AbMole
CASRN	145781-92-6
Amount	50mg
Category	Oncology Food Safety Hormones Inhibitors & Compound Libraries Small Molecules By Organ Testicular & Prostate Cancer Uterine, Ovarian & Cervical Cancer
Type	Inhibitors
Specific against	other
Purity	>98%
Citations	Goserelin and bicalutamide treatments alter the expression of microRNAs in the prostate. Lehmusvaara, et al . Prostate. 2012 Jun 5. PMID: 22674191 . Stimulation of a non-functioning pituitary macroadenoma after administration of goserelin acetate for locally advanced prostate cancer causing a sustained elevation in PSA and testosterone. Youssef, et al . Can Urol Assoc J. 2012 Apr,6(2):E84-6. PMID: 22511442 .
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	ICI-118630 acetate
Similar products	Goserelin
Available
Target Information	LHRH/GnRH
Molecular Weight	1329, 46
Solubility	DMSO
Bioactivity information	Goserelin acetate is an injectable gonadotropin releasing hormone superagonist (GnRH agonist), also known as a luteinizing hormone releasing hormone (LHRH) agonist.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

M1835-50mg-safety-datasheet.pdf